Neoadjuvant Chemoradiotherapy for Stage I and II Esophageal Cancer

被引：4
|
作者：
van Rossum, Peter S. N. [1 ]
van Hillegersberg, Richard [1 ]
Reerink, Onne [1 ]
Ruurda, Jelle P. [1 ]
机构：
[1] Univ Med Ctr Utrecht, Utrecht, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 03期
关键词：
PATHOLOGICAL RESPONSE; SURGERY;
D O I：
10.1200/JCO.2014.58.1272
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：287 / U170
页数：3
相关论文
共 50 条
  • [1] Effectiveness of Neoadjuvant Chemoradiotherapy for Early-Stage Esophageal Cancer
    Shapiro, Joel
    van Lanschot, J. Jan B.
    Hulshof, Maarten C. C. M.
    van der Gaast, Ate
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03) : 288 - 289
  • [2] Concurrent Chemoradiotherapy (CCRT) for Stage I-II Esophageal Cancer Patients
    Fukada, J.
    Kumabe, A.
    Kota, R.
    Koike, N.
    Toyama, H.
    Shiraishi, Y.
    Kitagawa, Y.
    Shigematsu, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E27 - E27
  • [3] Neoadjuvant Chemoradiotherapy for Stage II or III Esophageal Squamous Cell Carcinoma
    Kawai, Takaharu
    Kochi, Mitsugu
    Fujii, Masashi
    Song, Keio
    Hagiwara, Ken
    Watanabe, Megumu
    Matsuno, Yoritaka
    Suda, Hiroshi
    Yagi, Renpei
    Takayama, Tadatoshi
    ANTICANCER RESEARCH, 2017, 37 (06) : 3301 - 3306
  • [4] Neoadjuvant chemoradiotherapy for esophageal cancer - Is it worthwhile?
    Tamim, WZ
    Davidson, RS
    Quinlan, RM
    O'Shea, MA
    Orr, RK
    Swanson, RS
    ARCHIVES OF SURGERY, 1998, 133 (07) : 722 - 726
  • [5] Neoadjuvant Versus Definitive Concurrent Chemoradiotherapy In Stage III Esophageal Cancer Patients
    Chen, H. L.
    Chou, Y. H.
    Lee, Y.
    Tseng, H. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E656 - E656
  • [6] The Impact of Neoadjuvant Chemoradiotherapy on Perioperative Outcomes, Tumor Pathology, and Survival in Clinical Stage II and III Esophageal Cancer
    Markar, Sheraz R.
    Bodnar, Artur
    Rosales, Joseph
    Song, Guobin
    Low, Donald E.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (12) : 3935 - 3941
  • [7] The Impact of Neoadjuvant Chemoradiotherapy on Perioperative Outcomes, Tumor Pathology, and Survival in Clinical Stage II and III Esophageal Cancer
    Sheraz R. Markar
    Artur Bodnar
    Joseph Rosales
    Guobin Song
    Donald E. Low
    Annals of Surgical Oncology, 2013, 20 : 3935 - 3941
  • [8] Neoadjuvant Chemoradiotherapy for Clinical Stage II-III Esophageal Squamous Cell Carcinoma
    Saeki, Hiroshi
    Morita, Masaru
    Nakashima, Yuichiro
    Sonoda, Hideto
    Hashimoto, Kenkichi
    Egashira, Akinori
    Oki, Eiji
    Ohga, Takefumi
    Kakeji, Yoshihiro
    Maehara, Yoshihiko
    ANTICANCER RESEARCH, 2011, 31 (09) : 3073 - 3077
  • [9] Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma
    Barbetta, Arianna
    Hsu, Meier
    Tan, Kay See
    Stefanova, Dessislava
    Herman, Koby
    Adusumilli, Prasad S.
    Bains, Manjit S.
    Bott, Matthew J.
    Isbell, James M.
    Janjigian, Yelena Y.
    Ku, Geoffrey Y.
    Park, Bernard J.
    Wu, Abraham J.
    Jones, David R.
    Molena, Daniela
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 155 (06): : 2710 - 2719
  • [10] Esophageal cancer: improved prognosis with neoadjuvant chemoradiotherapy
    Knippen, Stefan
    Duma, Marciana-Nona
    STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (01) : 86 - 88
12345